Showing results (41-50 of 76) with videos related to
Sort By:
Pageof 8
American Journal of Respiratory and Critical Care Medicine|October 1, 1996
Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibodyD C Underwood, R R Osborn, S J Newsholme, et al.The Journal of Pharmacology and Experimental Therapeutics|June 1, 1995
Inhibitors of phosphodiesterase IV (PDE IV) increase acid secretion in rabbit isolated gastric glands: correlation between function and interaction with a high-affinity rolipram binding siteM S Barnette, M Grous, L B Cieslinski, et al.Blood|February 1, 1997
Inactivation of recombinant monocyte cAMP-specific phosphodiesterase by cAMP analog, 8-[(4-bromo-2,3-dioxobutyl)thio]adenosine 3',5'-cyclic monophosphateG A Omburo, T J Torphy, G Scott, et al.The Journal of Pharmacology and Experimental Therapeutics|May 1, 1985
Inhibitory effect of methacholine on drug-induced relaxation, cyclic AMP accumulation, and cyclic AMP-dependent protein kinase activation in canine tracheal smooth muscleT J Torphy, C Zheng, S M Peterson, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1993
Influence of isoproterenol and phosphodiesterase inhibitors on platelet-activating factor biosynthesis in the human neutrophilA N Fonteh, J D Winkler, T J Torphy, et al.Molecular Pharmacology|June 1, 1997
Role of conserved histidines in catalytic activity and inhibitor binding of human recombinant phosphodiesterase 4AS Jacobitz, M D Ryan, M M McLaughlin, et al.Inflammation|June 1, 1993
Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory responseD E Griswold, E F Webb, J Breton, et al.The Journal of Pharmacology and Experimental Therapeutics|May 1, 1995
The ability of phosphodiesterase IV inhibitors to suppress superoxide production in guinea pig eosinophils is correlated with inhibition of phosphodiesterase IV catalytic activityM S Barnette, C D Manning, L B Cieslinski, et al.Journal of Immunological Methods|September 9, 1996
Evaluation of human cytokine production and effects of pharmacological agents in a heterologous system in vivoD E Griswold, L M Hillegass, J O'Leary-Bartus, et al.The Journal of Biological Chemistry|October 6, 1995
Salbutamol up-regulates PDE4 activity and induces a heterologous desensitization of U937 cells to prostaglandin E2. Implications for the therapeutic use of beta-adrenoceptor agonistsT J Torphy, H L Zhou, J J Foley, et al.Pageof 8